plasticker-News
Anzeige
| 2009-09-18 |
|
Bayer: Dr. Marijn E. Dekkers designated Chairman of the Board of Management
 Following the Annual Stockholders’ Meeting on April 30, 2010, the present CFO Klaus Kühn will take early retirement at the age of 58. The Supervisory Board has appointed Werner Baumann (46), currently a member of both the Board of Management and Executive Committee of Bayer HealthCare, to be Kühn’s successor. Baumann will also join the Bayer Management Board on January 1, 2010. Advert About Dr. Marijn E. Dekkers
In Dr. Dekkers, who holds both Dutch and U.S. citizenship, Bayer is gaining as its CEO a highly experienced international manager. Born on September 22, 1957 in the southern Dutch city of Tilburg, Dekkers studied chemistry at the universities of Nijmegen and Eindhoven on graduating from high school. As his father was the general manager of a large textile company, he recognized at an early stage the significance of international experience in career progression. Immediately after completing his Ph.D. studies in 1985, the future Bayer CEO moved to the United States to start his career in research at General Electric in Schenectady, New York. At that time, this company’s R&D center employed 2,000 scientists and was one of the oldest and most respected research facilities in North America. Dekkers originally planned this position only as a way station en route to a university professorship. However, he enjoyed working in industry so much that he stayed. Two years later, he returned to the Netherlands to work at the GE Plastics research facility in Bergen op Zoom. When the post of his former U.S. supervisor became vacant in 1988, he recrossed the Atlantic to head polymer materials research in the United States. During this time he was elected “Technologist of the Year” at GE Plastics and contributed to 30 patents. Dr. Dekkers held management positions in various other polymers units at GE before moving to AlliedSignal (subsequently Honeywell International Inc.) in 1995. For four years he subsequently headed this company’s Specialty Films and Fluorine Chemicals business groups based in Morristown, New Jersey, moving in 1999 to head Electronic Materials in San Jose in California’s Silicon Valley. This business group manufactures electronic components, supplying companies such as Intel and Cisco. In 2000, Marijn Dekkers was offered the position of Chief Operating Officer with Boston-based Thermo Electron Corporation, one of the world’s leading specialists in the manufacture of laboratory instruments such as chromatographs and mass spectrometers used in life science research. The offer included the perspective of becoming the company’s CEO at a later date - and thus began a nine-year success story. Within a short time, Dekkers implemented a complete corporate reorganization and, when he became President and CEO as planned in 2002, the company had a workforce of 11,000 with sales of USD 2.2 billion. In his role as CEO he initiated further extensive restructuring measures, divesting various organizational units and strengthening the company’s core business by means of targeted acquisitions, including the purchase in 2006 of the significantly larger laboratory consumables supplier Fisher Scientific. Dekkers thereby created a company which now employs 35,000 people in six business groups and generates annual sales of USD 10.5 billion. Two years ago, Marijn Dekkers was also elected to the Board of Directors of Biogen Idec, one of the world’s leading biotechnology companies based in Cambridge, Massachusetts, with offices in 27 countries. Dr. Dekkers is married to an American and has three daughters. As a student, he was one of the best tennis players in the Netherlands, playing on a semi-professional basis in Germany’s top league for a number of years. Photo: Dr. Marijn E. Dekkers, designated Chairman of the Board of Management. |
Bayer AG, Leverkusen, Germany
 back to news list | back to top |
